motixafortide   Click here for help

GtoPdb Ligand ID: 10679

Synonyms: 4F-Benzoyl-TN14003 | Aphexda® | BKT140 | BL-8040 | TF14016 [4]
Approved drug Immunopharmacology Ligand
motixafortide is an approved drug (FDA (2023))
Comment: Motixafortide (BL8040) is a CXCR4 antagonist that is being developed by Biokine Therapeutics [1]. It is a 14-residue polypeptide modified from a naturally occurring horseshoe crab protein. Motixafortide acts as an inverse agonist in [35S]GTPγS binding assays [1]. It induces safe and efficient stem cell mobilisation in MM patients in preparation for autologous stem cell transplantation [3], and it is being proposed as a mechanism to improve anti-tumour immune reponse against solid tumours [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCCC[C@@H]1NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)CCCCN)CCC2)Cc1ccc(cc1)O)CCCNC(=N)N)CCCNC(=O)N)C(=O)N[C@H](C(=O)N)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1ccc(cc1)F)CCCNC(=N)N)CCCNC(=N)N)Cc1ccc2c(c1)cccc2
Isomeric SMILES NCCCC[C@@H]1NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)CCCCN)CCC2)Cc1ccc(cc1)O)CCCNC(=N)N)CCCNC(=O)N)C(=O)N[C@H](C(=O)N)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1ccc(cc1)F)CCCNC(=N)N)CCCNC(=N)N)Cc1ccc2c(c1)cccc2
InChI InChI=1S/C97H144FN33O19S2/c98-60-33-31-58(32-34-60)78(135)119-65(19-8-42-113-93(104)105)79(136)121-68(21-10-44-115-95(108)109)83(140)126-73(51-56-25-30-57-14-1-2-15-59(57)48-56)87(144)130-75-53-152-151-52-74(88(145)118-63(77(101)134)18-7-41-112-92(102)103)129-84(141)69(23-12-46-117-97(111)150)122-81(138)66(20-9-43-114-94(106)107)124-86(143)72(50-55-28-37-62(133)38-29-55)128-90(147)76-24-13-47-131(76)91(148)70(17-4-6-40-100)125-82(139)64(16-3-5-39-99)120-80(137)67(22-11-45-116-96(110)149)123-85(142)71(127-89(75)146)49-54-26-35-61(132)36-27-54/h1-2,14-15,25-38,48,63-76,132-133H,3-13,16-24,39-47,49-53,99-100H2,(H2,101,134)(H,118,145)(H,119,135)(H,120,137)(H,121,136)(H,122,138)(H,123,142)(H,124,143)(H,125,139)(H,126,140)(H,127,146)(H,128,147)(H,129,141)(H,130,144)(H4,102,103,112)(H4,104,105,113)(H4,106,107,114)(H4,108,109,115)(H3,110,116,149)(H3,111,117,150)/t63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-/m0/s1
InChI Key JJVZSYKFCOBILL-MKMRYRNGSA-N
Classification Click here for help
Compound class Peptide or derivative
Approved drug? Yes (FDA (2023))
International Nonproprietary Names Click here for help
INN number INN
10935 motixafortide
Synonyms Click here for help
4F-Benzoyl-TN14003 | Aphexda® | BKT140 | BL-8040 | TF14016 [4]
Database Links Click here for help
Specialist databases
GPCRdb Ligand motixafortide
Other databases
CAS Registry No. 664334-36-5 (source: WHO INN record)
GtoPdb PubChem SID 404859126
PubChem CID 91865076
Search Google for chemical match using the InChIKey JJVZSYKFCOBILL-MKMRYRNGSA-N
Search Google for chemicals with the same backbone JJVZSYKFCOBILL
Search PubMed clinical trials motixafortide
Search PubMed titles motixafortide
Search PubMed titles/abstracts motixafortide
UniChem Compound Search for chemical match using the InChIKey JJVZSYKFCOBILL-MKMRYRNGSA-N
UniChem Connectivity Search for chemical match using the InChIKey JJVZSYKFCOBILL-MKMRYRNGSA-N